RNS System LGS Feasibility Study
Trial details
- Registry ID
- NCT05339126
- Phase
- Phase 2
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| RNS System LGS Feasibility StudyNCT05339126 | NeuroPace | Phase 2 | Active not recruiting | 2026-11-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |